IntroductionThe effects of traumatic brain injury (TBI) can result in severe disability or death [1,2] and have an important social and economic impact [1]. The annual direct and indirect costs of TBI amount to roughly 2.5 billion euros [1,3]. MRI performed within the first 8 days after head injury was found to be a reliable predictor of death and moderate/severe disability for patients in coma and on ventilation following TBI, depending on the location of the lesion [4]. Apart from imaging signs, other easy-to-assess early predictors of outcome are lacking. As such, there is an on-going effort to identify biological markers that are closely related to clinical symptoms in order to better predict the outcome after TBI.The recent adoption of high throughput technologies and a change in focus from the identification of single to multiple markers has fostered new optimism in this direction [5][6][7]. Different markers have been studied, particularly bivalent cations such as magnesium (Mg 2+ ) and calcium (Ca 2+ ) [5][6][7]. Of these, calcium seems to play a more important role in TBI [5,8]. A study performed in 2010 compared statins (cholesterol-lowering drugs) as inductors of an anti-inflammatory effect, promoting recovery after moderate/severe TBI. The results showed that patients with a lower serum calcium level on day 3 died earlier than those patients who had a normal serum calcium level on day 3 after TBI. This led to the development of an ambispective study including a total of 122 Mexican patients suffering from moderate/ severe TBI, which showed that hypocalcaemia on day 3 seemed to be a reliable predictor of mortality after TBI, reaching significant levels (P=0.026) [6]. However, morbidity was not assessed. Our objective was to evaluate whether hypocalcaemia of serum ionized calcium (defined as <1.10 mmol/L (4.5 mg/dL) is a prognostic factor for mortality and morbidity (defined as GOS ≤ 3) in early moderate and severe TBI.
AbstractIntroduction: The effects of traumatic brain injury (TBI) can result in severe disability or death and have an important social and economic impact. Its annual direct and indirect costs amount to roughly 2.5 billion euros. Our objective was to evaluate whether hypocalcaemia of serum ionized calcium (defined as <1.10 mmol/L (4.5 mg/dL) is a prognostic factor for mortality and morbidity (defined as GOS ≤ 3) in early moderate and severe TBI.